Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential CFA vs CFA + rFSH for Elective Fertility Preservation (2-Shot)
NCT06134479Phase 3Completed
- Sponsor
- Fundació Santiago Dexeus Font
- Start
- Dec 2023
- Primary completion
- Sep 2025
- Modality
- rProtein (Recombinant Protein), Hormone, Biologic
- Countries
- 1
01
Overview
Phase 3, randomised trial of corifollitropin alfa in infertility (2 arms), sponsored by Fundació Santiago Dexeus Font. Primary endpoint: Number of Metaphase II oocytes retrieved. Started Dec 2023; status: completed.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT06134479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06134479.